Study finds a subset of artificial heart patients can regenerate heart muscle

A2 Bio has two ongoing Phase I/II clinical trials investigating two of its CAR-T programmes. Credit: THOMAS COEX via Getty Images. US-based biotech company A2

WASHINGTON — Apraglutide, an investigational long-acting synthetic GLP-2 analog, reduced the need for parenteral support in patients with short bowel syndrome and intestinal failure (SBS-IF),

WASHINGTON — Five healthcare companies took another step toward becoming part of a nationwide network to exchange patient health information on Tuesday. “I feel like